Watchlist for July 17, 2007

It looks like a slightly higher open today. I’m watching & waiting for a break of yesterday’s ranges on the Nasdaq and S&P 500.

On Today’s Calendar:

• pre-market — PPI
• pre-market — Capacity Utilization
• pre-market — Industrial Production

More Calendars: U.S. Earnings | Conf. Calls | Surprises | IPO | Economic

Potential swing trades:

See one of the recent ‘Chart Reading‘ posts for some potential swing candidates.

Potential day trades:

(From Briefing.com)

Gapping Down

Gapping down on weak earnings/guidance: XING -19.8%, NLS -15.7%, PHTN -15.3%, IPCR -6.9%, MTOX -6.4%… Other news: MBRX -58.0% (announces CS-917 Phase 2b clinical trial results; failed to significantly lower the placebo-adjusted level of glycosylated) JADE -10.9% (to delay filing its 2006 Form 20-F), DYII -7.6% (profit taking following yesterday’s 220% move higher following earnings), BTJ -5.2% (initiated with a Sell at Dahlman Rose; tgt $40); KG -4.5% (downgraded to Sell at Citigroup; this follows yesterday’s ~7% drop), PXP -4.3% (co to acquire PPP for approx $3.6 bln), BHP -1.4% (downgraded to Hold at Deutsche Bank).

Gapping Up

Gapping up on strong earnings/guidance: QEPC +71%, JEF +4.0%, NVLS +3.6%, STT +2.3%… M&A: LYO +16.6% (Basell to acquire LYO for $48 per share)… Other news: COR +16.1% (to resume clinical trial with Ampakine CX717 in Alzheimer-PET Scan Study after FDA approves protocol with higher doses of drug), DRRX +11.5% (reports positive results from posidur Phase IIb Hernia Trial, triggering $8 mln milestone pmt), NPSP +7.9% (announces sale of Preotact royalty to Drug Royalty), CTIC +5.9% (checking for any news), NHWK +5.0% (announces acquisition of Midwest Physician Services), RAME +3.8% (announced Q2 operational update; tgt upped at to $6.75 from $6.00 at Jefferies), NFI +3.6% (announces investment of $48.8 mln by MassMutual and Jefferies), ROH +3.5% (authorized $2 bln share repurchase program after the close yesterday; upgraded to Buy at Citigroup this morning), LEA +3.1% (continued momentum following yesterday’s rejection of AREP’s bid; stock was upgraded to Overweight at JP Morgan this morning).

Disclaimer & How I use this list